Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production
出版年份 2011 全文链接
标题
Human mesenchymal stem cells inhibit osteoclastogenesis through osteoprotegerin production
作者
关键词
-
出版物
ARTHRITIS AND RHEUMATISM
Volume 63, Issue 6, Pages 1658-1667
出版商
Wiley
发表日期
2011-02-27
DOI
10.1002/art.30309
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation
- (2010) Shigeru Kotake et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Therapeutic implications of osteoprotegerin
- (2009) Sofia Fili et al. Cancer Cell International
- Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10
- (2009) Seung-Ha Yang et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Osteoblast Function Is Compromised at Sites of Focal Bone Erosion in Inflammatory Arthritis
- (2009) Nicole C Walsh et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Mesenchymal Stromal Cells Ameliorate Experimental Autoimmune Encephalomyelitis by Inhibiting CD4 Th17 T Cells in a CC Chemokine Ligand 2-Dependent Manner
- (2009) Moutih Rafei et al. JOURNAL OF IMMUNOLOGY
- IL-10 Suppresses Calcium-Mediated Costimulation of Receptor Activator NF- B Signaling during Human Osteoclast Differentiation by Inhibiting TREM-2 Expression
- (2009) K.-H. Park-Min et al. JOURNAL OF IMMUNOLOGY
- Osteoimmunology and the effects of the immune system on bone
- (2009) Hiroshi Takayanagi Nature Reviews Rheumatology
- Mesenchymal stem cells: innovative therapeutic tools for rheumatic diseases
- (2009) Farida Djouad et al. Nature Reviews Rheumatology
- Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial
- (2008) Stanley B. Cohen et al. ARTHRITIS AND RHEUMATISM
- Interleukin-6 Inhibits Receptor Activator of Nuclear Factor κB Ligand-Induced Osteoclastogenesis by Diverting Cells into the Macrophage Lineage: Key Role of Serine727Phosphorylation of Signal Transducer and Activator of Transcription 3
- (2008) Laurence Duplomb et al. ENDOCRINOLOGY
- Interleukin-6 Directly Inhibits Osteoclast Differentiation by Suppressing Receptor Activator of NF-κB Signaling Pathways
- (2008) Fumio Yoshitake et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Why are MSCs therapeutic? New data: new insight
- (2008) AI Caplan JOURNAL OF PATHOLOGY
- Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
- (2008) Josef S Smolen et al. LANCET
- Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
- (2008) Katarina Le Blanc et al. LANCET
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J)
- (2008) Tsutomu Takeuchi et al. Modern Rheumatology
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year clinical outcomes (RECONFIRM-2)
- (2008) Yoshiya Tanaka et al. Modern Rheumatology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started